Preclinical and clinical issues in Alzheimer's disease drug research and development
Alzheimer's disease (AD) is a chronic neurodegenerative disorder characterized by progressive cognitive dysfunction and memory loss, inability to perform the activities of daily living and mood disorders. According to the so-called "amyloid cascade hypothesis", amyloid-ß- peptide (Aß)...
Salvato in:
Autore principale: | Silvana Gaetani (auth) |
---|---|
Altri autori: | Cesare Mancuso (auth) |
Natura: | Elettronico Capitolo di libro |
Lingua: | inglese |
Pubblicazione: |
Frontiers Media SA
2015
|
Serie: | Frontiers Research Topics
|
Soggetti: | |
Accesso online: | DOAB: download the publication DOAB: description of the publication |
Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
|
Documenti analoghi
-
Alzheimer's Disease: Original Mechanisms and Translational Impact
Pubblicazione: (2020) -
Behold the Eye in Parkinson's Disease & Alzheimer's Disease
Pubblicazione: (2020) -
New Paradigms in Neuroscience and Related Targets for Drug Discovery
Pubblicazione: (2020) -
Preclinical and clinical issues in Alzheimer's disease drug research and development.
di: Cesare eMancuso, et al.
Pubblicazione: (2014) -
Pharmacogenetics
Pubblicazione: (2021)